MM&M: RFK Jr.’s HHS gutted OPDP. How will it impact pharma advertising? Pharma brands spend billions of dollars every year on poorly targeted TV advertising.
A new startup called BranchLab, which was launched earlier this year by three ad tech vets, wants to change that. Palm Beach Post: RFK Jr. discusses federal policies aimed at reducing pharmaceutical advertising MM&M: How the FDA’s crackdown on pharma ads may play out legally Legal and regulatory experts expect the FDA’s new DTC ad crackdown to face legal challenges. While the FDA’s letters to drugmakers were unprecedented, it may be difficult for the agency to actually ...
pharma advertising agency, Omnicom has struck a deal to merge with Interpublic Group, bringing together marketing and sales firms that generated a combined $3.7 billion in pharmaceuticals and healthcare revenues over the first ... Fast Company: The evolution of pharma marketing: How to reach consumers in the age of digital health Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and personalized experiences. The Fast Company Executive Board is a private, ...
